Suppr超能文献

后生动物蛋白质解聚酶和淀粉样蛋白解聚酶系统:热休克蛋白110、热休克蛋白70、热休克蛋白40和小分子热休克蛋白。

The metazoan protein disaggregase and amyloid depolymerase system: Hsp110, Hsp70, Hsp40, and small heat shock proteins.

作者信息

Torrente Mariana P, Shorter James

机构信息

Department of Biochemistry and Biophysics; 805b Stellar-Chance Laboratories; Perelman School of Medicine; University of Pennsylvania; Philadelphia, PA USA.

出版信息

Prion. 2013 Nov-Dec;7(6):457-63. doi: 10.4161/pri.27531. Epub 2014 Jan 8.

Abstract

A baffling aspect of metazoan proteostasis is the lack of an Hsp104 ortholog that rapidly disaggregates and reactivates misfolded polypeptides trapped in stress induced disordered aggregates, preamyloid oligomers, or amyloid fibrils. By contrast, in bacteria, protozoa, chromista, fungi, and plants, Hsp104 orthologs are highly conserved and confer huge selective advantages in stress tolerance. Moreover, in fungi, the amyloid remodeling activity of Hsp104 has enabled deployment of prions for various beneficial modalities. Thus, a longstanding conundrum has remained unanswered: how do metazoan cells renature aggregated proteins or resolve amyloid fibrils without Hsp104? Here, we highlight recent advances that unveil the metazoan protein-disaggregase machinery, comprising Hsp110, Hsp70, and Hsp40, which synergize to dissolve disordered aggregates, but are unable to rapidly solubilize stable amyloid fibrils. However, Hsp110, Hsp70, and Hsp40 exploit the slow monomer exchange dynamics of amyloid, and can slowly depolymerize amyloid fibrils from their ends in a manner that is stimulated by small heat shock proteins. Upregulation of this system could have key therapeutic applications in various protein-misfolding disorders. Intriguingly, yeast Hsp104 can interface with metazoan Hsp110, Hsp70, and Hsp40 to rapidly eliminate disease associated amyloid. Thus, metazoan proteostasis is receptive to augmentation with exogenous disaggregases, which opens a number of therapeutic opportunities.

摘要

后生动物蛋白质稳态中一个令人困惑的方面是缺乏Hsp104直系同源物,这种同源物能够快速分解并重新激活被困在应激诱导的无序聚集体、淀粉样前体寡聚体或淀粉样纤维中的错误折叠多肽。相比之下,在细菌、原生动物、色素界、真菌和植物中,Hsp104直系同源物高度保守,并在应激耐受性方面赋予巨大的选择优势。此外,在真菌中,Hsp104的淀粉样重塑活性使得朊病毒能够用于各种有益的模式。因此,一个长期存在的难题一直没有得到解答:后生动物细胞如何在没有Hsp104的情况下使聚集的蛋白质复性或分解淀粉样纤维?在这里,我们重点介绍了最近的进展,这些进展揭示了后生动物蛋白质解聚酶机制,该机制由Hsp110、Hsp70和Hsp40组成,它们协同作用以溶解无序聚集体,但无法快速溶解稳定的淀粉样纤维。然而,Hsp110、Hsp70和Hsp40利用淀粉样蛋白缓慢的单体交换动力学,并且可以以小热休克蛋白刺激的方式从其末端缓慢解聚淀粉样纤维。该系统的上调可能在各种蛋白质错误折叠疾病中具有关键的治疗应用。有趣的是,酵母Hsp104可以与后生动物的Hsp110、Hsp70和Hsp40相互作用,以快速消除与疾病相关的淀粉样蛋白。因此,后生动物蛋白质稳态易于通过外源性解聚酶增强,这开启了许多治疗机会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d52b/4201613/7b7df75e404e/prio-7-457-g1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验